Can (18)F-Fluoroestradiol Positron Emission Tomography Become a New Imaging Standard in the Estrogen Receptor-positive Breast Cancer Patient: A Prospective Comparative Study with (18)F-Fluorodeoxyglucose Positron Emission Tomography?

Correct staging is the most crucial for the treatment outcome in cancer management. Molecular imaging with (18)F-fluoroestradiol (FES) positron emission tomography-computed tomography (PET-CT) targets estrogen receptor (ER) and may have a higher incremental value in diagnosis by aiding specificity....

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Manoj, Datta, Anupama, Choudhury, Partha S., Dsouza, Maria, Batra, Ullas, Mishra, Anil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436319/
https://www.ncbi.nlm.nih.gov/pubmed/28553180
http://dx.doi.org/10.4103/1450-1147.203071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436319/
https://www.ncbi.nlm.nih.gov/pubmed/28553180
http://dx.doi.org/10.4103/1450-1147.203071

Ejemplares similares